{"abstract":"The Food and Drug Administration (FDA or Agency) is amending the standing advisory committee regulations to add the establishment of the Genetic Metabolic Diseases Advisory Committee (GeMDAC or the Committee) to the list of standing committees.","action":"Final rule.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/03/06/2024-04751.html","cfr_references":[{"chapter":null,"citation_url":null,"part":14,"title":21}],"citation":"89 FR 15959","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"This rule is effective March 6, 2024.","disposition_notes":null,"docket_ids":["Docket No. FDA-2024-N-0826"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2024-03-06","updated_at":"2024-09-03T16:45:44.687-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2024-N-0826-0001","allow_late_comments":false,"id":"FDA-2024-N-0826-0001","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2024-N-0826","title":"Advisory Committee; Genetic Metabolic Diseases Advisory Committee; addition to List of Standing Committees"}],"document_number":"2024-04751","effective_on":"2024-03-06","end_page":15959,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/03/06/2024-04751.xml","html_url":"https://www.federalregister.gov/documents/2024/03/06/2024-04751/advisory-committee-genetic-metabolic-diseases-advisory-committee-addition-to-list-of-standing","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-04751?publication_date=2024-03-06","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-03-06/2024-04751/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":209,"last_updated":"2026-04-04 14:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-03-06/pdf/2024-04751.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-04751.pdf?1709646334","publication_date":"2024-03-06","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/03/06/2024-04751.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2024-N-0826","supporting_documents_count":0,"docket_id":"FDA-2024-N-0826","document_id":"FDA-2024-N-0826-0001","regulation_id_number":null,"title":"Advisory Committee; Genetic Metabolic Diseases Advisory Committee; addition to List of Standing Committees","checked_regulationsdotgov_at":"2024-03-07T14:00:09Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":15959,"subtype":null,"title":"Advisory Committee; Genetic Metabolic Diseases Advisory Committee; Addition to List of Standing Committees","toc_doc":"Metabolic Diseases Advisory Committee; Addition","toc_subject":"List of Standing Committees:\n","topics":["Administrative practice and procedure","Advisory committees","Color additives","Drugs","Radiation protection"],"type":"Rule","volume":89}